Skip to main content

Construction and validation of tissue microarrays of ductal carcinoma in situ and terminal duct lobular units associated with invasive breast carcinoma.

Yang XR, Charette LA, Garcia-Closas M, Lissowska J, Paal E, Sidawy M, Hewitt SM, Rimm DL, Sherman ME

Publication: Diagn Mol Pathol (2006) • Vol 15 • Page 157-61PMID: 16932071View on PubMed

Purpose

The purpose of this paper was to determine the effects of selected area and section number on tumor representation and immunohistochemical (IHC) staining of estrogen receptor (ER) and progesterone receptor (PR) in tissue microarrays (TMAs).

Conclusion

In the first TMA sections, a larger percentage of invasive carcinomas than non-invasive targets cored had adequate representation, and while there was no effect of section number on adequate representation of invasive carcinomas, non-invasive carcinomas had decreased representation after section 30. In normal adjacent tissue, core loss occurred only when the target was 2-3 mM in diameter, but in non-invasive breast tumors, arraying failure was more common when the target was in the periphery of the tissue block and was not size related. For the tumor blocks from which multiple terminal duct lobular units (TDLU) or non-invasive breast tumor cores were available, ER and PR positivity/intensity were generally classified in the same category for all cores, but in some cases, staining positivity or intensity differed by one category.

Studies (1)

Purpose

The purpose of this study was to determine the effects of tumor heterogeneity and section number on IHC staining of ER and PR in TMAs containing breast cancer specimens. The effect of counting rather than subjective quantification of IHC staining was also investigated. The 2 arrays consisted of single 2.0 mM cores selected from representative areas. IHC staining was either classified into 3 categories (less than 10%, 10-50%, or more than 50%) or by intensity based on subjective quantification (negative, weak, intermediate, or strong).

Summary of Findings

In the first sections, 91% of invasive carcinoma specimens had adequate representation in the TMA, defined as more than 10% terminal duct lobular units (TDLU), or more than 10% representation of tumor targets. For non-invasive targets, only 79% of specimens had adequate representation in the TMA. In normal adjacent tissue, core loss occurred only when the target was 2-3 mM in diameter, but in DCIS specimens, arraying failure was more common when the target was in the periphery of the tissue block and was not size related. Representation of tumor tissue was similar for at least the first 100 sections taken from the TMA for invasive tumors, but for non-invasive carcinoma, adequate representation declined after the 30th section, including only 52% of cases by the 100th section. The number of tubules as determined by subjective estimation was concordant with counting results in 70.8% of cases for ER and 79.2% of cases for PR. For the 6 tumor blocks from which multiple TDLU or DCIS cores were available, ER and PR positivity/intensity were generally classified in the same category for all cores, but in some cases, staining positivity or intensity differed by one category.
  • Biospecimens

    TissueBreast
  • Preservation Types

    Formalin
  • Diagnoses

    NeoplasticCarcinoma
    NeoplasticNormal Adjacent
  • Platforms

    ProteinImmunohistochemistry
    MorphologyH-and-E microscopy
    ProteinTissue microarray
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Ductal carcinoma in situ
    Invasive breast cancer
    Biospecimen Aliquots and ComponentsAliquot sequential collection
    100'th section
    1st section
    20'th section
    30'th section
    40th section
    50'th section
    60'th section
    70'th section
    80'th section
    90'th section
    Biospecimen Aliquots and ComponentsBiospecimen heterogeneity
    Biospecimen core
    Biospecimen periphery
    Immunohistochemistry SpecificData handling
    Calculated staining percentage
    Subjective staining estimation
    Immunohistochemistry SpecificTargeted peptide/protein
    ER
    PR